Mesenchymal Cell News Volume 14.47 | Nov 30 2022

    0
    24








    2022-11-30 | MESCN 14.47


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.47 – 30 November, 2022
    TOP STORY

    circCsnk1g3- and circAnkib1-Regulated Interferon Responses in Sarcoma Promote Tumorigenesis by Shaping the Immune Microenvironment

    Scientists identified the circular RNAs (circRNAs) expressed in soft tissue sarcoma cells and explored how the circRNAs regulated sarcoma growth in vivo.
    [Nature Communications]

    Full Article
    Latest updates and debates on mesenchymal stem cells.
    PUBLICATIONSRanked by the impact factor of the journal

    Fibrin Glue Does Not Promote Migration and Proliferation of Bone Marrow Derived Mesenchymal Stem Cells in Collagenic Membranes: An In Vitro Study

    Investigators evaluated the impact of fibrin glue addition to biologic membranes loaded with bone marrow-derived MSCs (B-MSCs). B-MSCs were harvested from three different unrelated donors.
    [Scientific Reports]

    Full Article

    Binucleated Human Bone Marrow-Derived Mesenchymal Cells Can Be Formed during Neural-Like Differentiation with Independence of Any Cell Fusion Events

    Researchers demostrated that human bone marrow-derived cells (BMDCs) could rapidly adopt a neural-like morphology through active neurite extension, and binucleated human BMDCs could form with independence of any cell fusion events.
    [Scientific Reports]

    Full Article

    BACH1 Regulates the Proliferation and Odontoblastic Differentiation of Human Dental Pulp Stem Cells

    The authors investigated the effects of BTB and CNC homology 1 (BACH1) on the proliferation and odontoblastic differentiation of human dental pulp stem cells in vitro.
    [BMC Oral Health]

    Full Article

    MiR-145 Inhibits the Differentiation and Proliferation of Bone Marrow Stromal Mesenchymal Stem Cells by GABARAPL1 in Steroid-Induced Femoral Head Necrosis

    Investigators explored the specific mechanism of miR-145 involved in steroid-induced osteonecrosis of femoral head. Dexamethasone, a typical glucocorticoid, was used to induce osteogenic differentiation of bone marrow MSCs.
    [BMC Musculoskeletal Disorders]

    Full Article

    Mesenchymal Stem/Stromal Cells Primed by Inflammatory Cytokines Alleviate Psoriasis-Like Inflammation via the TSG-6-Neutrophil Axis

    Researchers found that subcutaneous application of umbilical cord-derived MSCs primed by interferon-γ and tumor necrosis factor-α exhibited remarkable therapeutic efficacy on imiquimod-induced psoriasis-like inflammation in mice.
    [Cell Death & Disease]

    Full Article

    Mesenchymal Stem Cells Loaded with Ad5-Ki67/IL-15 Enhance Oncolytic Adenovirotherapy in Experimental Glioblastoma

    Investigators loaded mouse bone marrow-derived MSCs with adenovirus (Ad)5-Ki67/IL-15 and observed the transduction, replication, and release of Ad5-Ki67/IL-15 in MSCs.
    [Biomedicine & Pharmacotherapy]

    Full Article

    Mesenchymal Stem Cells Alleviate Systemic Sclerosis by Inhibiting the Recruitment of Pathogenic Macrophages

    Scientists found that interferon-γ – and tumor necrosis factor-α-pretreated MSCs significantly alleviated skin fibrosis in a bleomycin-induced systemic sclerosis model.
    [Cell Death Discovery]

    Full Article

    Mesenchymal Stem Cells Suppressed Skin and Lung Inflammation and Fibrosis in Topoisomerase I-induced Systemic Sclerosis Associated with Lung Disease Mouse Model

    Researchers investigated the therapeutic effects and mechanisms of treatment of bone marrow-MSC derived from C57BL/6 on the topoisomerase I induced systemic sclerosis associated with lung interstitial lung disease like mice model.
    [Cell and Tissue Research]

    Abstract
    Find the Right Antibodies for Your Stem Cell Research. Learn More
    REVIEWS

    Differentiation of Osteoblasts: The Links between Essential Transcription Factors

    The authors discuss nine essential transcription factors involved in osteoblast differentiation, including Runx2, Osx, Dlx5, β-catenin, ATF4, Ihh, Satb2, and Shn3.
    [Journal of Biomolecular Structure and Dynamics]

    Abstract
    INDUSTRY AND POLICY NEWS

    Kala Pharmaceuticals Announces Submission of Investigational New Drug Application for KPI-012 for the Treatment of Persistent Corneal Epithelial Defect

    Kala Pharmaceuticals, Inc. announced the submission of an investigational new drug application to the US FDA for KPI-012, a human MSC secretome, for the treatment of persistent corneal epithelial defect.
    [Kala Pharmaceuticals, Inc.]

    Press Release
    FEATURED EVENT

    Drug Delivery to the Brain: Challenges and Progress

    January 23 – 25, 2023
    Breckenridge, Colorado, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Assistant – Sarcoma

    University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    Postdoctoral Fellow – Cancer/Stem Cell Biology

    City of Hope – Los Angeles, California, United States

    Lead Associate – Clinical Trials

    Takeda – Boston, Massachusetts, United States

    PhD positions – EuReCa PhD Program

    Institut Curie – Paris, France

    Postdoctoral Position – Biomedical Engineering

    Uppsala University – Uppsala, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter